Paradigm raises $1.5m to push global sales expansion of eye imager:

Executive Summary

Diagnostic systems developer Paradigm Medical Industries is to ramp up its global sales and marketing efforts, using the $1.5m it raised from a recent convertible note sale. The company will focus particularly on its lead product, the P60 Ultrasound BioMicroscope (UBM), a fourth-generation ultrasound device for imaging conditions of the eye. The system is approved in the US, various European and Pacific Rim countries and, most recently, in Canada (see Clinica No 1196, p 18). The proceeds from the note sale will also go towards building up the Salt Lake City, Utah firm's inventory.